Pharmafile Logo
Pharmafocus logo
Advanced Search

Endo International

Showing 3 posts of 3 posts found.

doc_writing

Endo to withdraw FDA application for abuse-deterrent labelling on opioid drug

August 15, 2016
Sales and Marketing Endo, Endo International, abuse deterrent, opioid

Endo International has announced that, following discussions with the US Food and Drug Administration (FDA), it has decided to withdraw …

News
stocks3

Endo shares plunge almost 40% as company cuts FY outlook

May 9, 2016
Sales and Marketing Endo International, earnings, outlook, revenue

Shares in Endo International (Nasdaq: ENDP) plunged to close down nearly 40% after the company cut its full-year earnings forecast …

News

FTC files complaint against Endo for blocking generics of its pain drugs

April 1, 2016
Business Services, Manufacturing and Production, Medical Communications, Sales and Marketing Endo International, FTC, legal, regulation

The US Federal Trade Commission (FTC) has filed a complaint against Endo International (Nasdaq: ENDP) alleging the company used illegal …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026